Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Abdominal Radiology
Published in: Abdominal Radiology 3/2018

01-03-2018 | Pictorial essay

A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system

Authors: Elizabeth A. Sadowski, Jessica B. Robbins, Andrea G. Rockall, Isabelle Thomassin-Naggara

Published in: Abdominal Radiology | Issue 3/2018

Login to get access

Abstract

Adnexal lesions are a common occurrence in radiology practice and imaging plays a crucial role in triaging women appropriately. Current trends toward early detection and characterization have increased the need for accurate imaging assessment of adnexal lesions prior to treatment. Ultrasound is the first-line imaging modality for assessing adnexal lesions; however, approximately 20% of lesions are incompletely characterized after ultrasound evaluation. Secondary assessment with MR imaging using the ADNEx MR Scoring System has been demonstrated as highly accurate in the characterization of adnexal lesions and in excluding ovarian cancer. This review will address the role of MR imaging in further assessment of adnexal lesions discovered on US, and the utility of the ADNEx MR Scoring System.
Literature
1.
Fishman DA, Cohen L, Blank SV, et al. (2005) The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. Am J Obstet Gynecol 192:1214–1221 (discussion 1221-1212)CrossRefPubMed
2.
Sharma A, Apostolidou S, Burnell M, et al. (2012) Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS). Ultrasound Obstet Gynecol 40:338–344CrossRefPubMed
3.
Stukan M, Dudziak M, Ratajczak K, Grabowski JP (2015) Usefulness of diagnostic indices comprising clinical, sonographic, and biomarker data for discriminating benign from malignant ovarian masses. J Ultrasound Med 34:207–217CrossRefPubMed
4.
Timmerman D, Ameye L, Fischerova D, et al. (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839CrossRefPubMedPubMedCentral
5.
Cadron I, Leunen K, Van Gorp T, et al. (2007) Management of borderline ovarian neoplasms. J Clin Oncol 25:2928–2937CrossRefPubMed
6.
Darai E, Fauvet R, Uzan C, et al. (2013) Fertility and borderline ovarian tumor: a systematic review of conservative management, risk of recurrence and alternative options. Hum Reprod Update 19:151–166CrossRefPubMed
7.
Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A (2006) Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol 100:185–191CrossRefPubMed
8.
Medeiros LR, Freitas LB, Rosa DD, et al. (2011) Accuracy of magnetic resonance imaging in ovarian tumor: a systematic quantitative review. Am J Obstet Gynecol 204:67.e61-10CrossRef
9.
Mohaghegh P, Rockall AG (2012) Imaging strategy for early ovarian cancer: characterization of adnexal masses with conventional and advanced imaging techniques. Radiographics 32:1751–1773CrossRefPubMed
10.
Sayasneh A, Ekechi C, Ferrara L, et al. (2015) The characteristic ultrasound features of specific types of ovarian pathology (review). Int J Oncol 46:445–458CrossRefPubMed
11.
Spencer JA, Ghattamaneni S (2010) MR imaging of the sonographically indeterminate adnexal mass. Radiology 256:677–694CrossRefPubMed
12.
Braicu EI, Sehouli J, Richter R, et al. (2012) Primary versus secondary cytoreduction for epithelial ovarian cancer: a paired analysis of tumour pattern and surgical outcome. Eur J Cancer 48:687–694CrossRefPubMed
13.
Bristow RE, Chang J, Ziogas A, Anton-Culver H (2013) Adherence to treatment guidelines for ovarian cancer as a measure of quality care. Obstet Gynecol 121:1226–1234CrossRefPubMed
14.
Earle CC, Schrag D, Neville BA, et al. (2006) Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients. J Natl Cancer Inst 98:172–180CrossRefPubMed
15.
Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R (2011) Optimal primary surgical treatment for advanced epithelial ovarian cancer. Cochrane Database Syst Rev 8:Cd007565
16.
Engelen MJ, Kos HE, Willemse PH, et al. (2006) Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106:589–598CrossRefPubMed
17.
Woo YL, Kyrgiou M, Bryant A, Everett T, Dickinson HO (2012) Centralisation of services for gynaecological cancers: a Cochrane systematic review. Gynecol Oncol 126:286–290CrossRefPubMed
18.
Vergote I, De Brabanter J, Fyles A, et al. (2001) Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176–182CrossRefPubMed
19.
Brown DL, Doubilet PM, Miller FH, et al. (1998) Benign and malignant ovarian masses: selection of the most discriminating gray-scale and Doppler sonographic features. Radiology 208:103–110CrossRefPubMed
20.
Buys SS, Partridge E, Greene MH, et al. (2005) Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 193:1630–1639CrossRefPubMed
21.
Castillo G, Alcazar JL, Jurado M (2004) Natural history of sonographically detected simple unilocular adnexal cysts in asymptomatic postmenopausal women. Gynecol Oncol 92:965–969CrossRefPubMed
22.
Ekerhovd E, Wienerroith H, Staudach A, Granberg S (2001) Preoperative assessment of unilocular adnexal cysts by transvaginal ultrasonography: a comparison between ultrasonographic morphologic imaging and histopathologic diagnosis. Am J Obstet Gynecol 184:48–54CrossRefPubMed
23.
Greenlee RT, Kessel B, Williams CR, et al. (2010) Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial. Am J Obstet Gynecol 202(373):e371–e379
24.
Levine D, Gosink BB, Wolf SI, Feldesman MR, Pretorius DH (1992) Simple adnexal cysts: the natural history in postmenopausal women. Radiology 184:653–659CrossRefPubMed
25.
Modesitt SC, Pavlik EJ, Ueland FR, et al. (2003) Risk of malignancy in unilocular ovarian cystic tumors less than 10 centimeters in diameter. Obst Gynecol 102:594–599
26.
Timor-Tritsch IE, Goldstein SR (2005) The complexity of a “complex mass” and the simplicity of a “simple cyst”. J Ultrasound Med 24:255–258CrossRefPubMed
27.
Valentin L, Ameye L, Franchi D, et al. (2013) Risk of malignancy in unilocular cysts: a study of 1148 adnexal masses classified as unilocular cysts at transvaginal ultrasound and review of the literature. Ultrasound Obstet Gynecol 41:80–89CrossRefPubMed
28.
Thomassin-Naggara I, Aubert E, Rockall A, et al. (2013) Adnexal masses: development and preliminary validation of an MR imaging scoring system. Radiology 267:432–443CrossRefPubMed
29.
Hricak H, Chen M, Coakley FV, et al. (2000) Complex adnexal masses: detection and characterization with MR imaging–multivariate analysis. Radiology 214:39–46CrossRefPubMed
30.
Sohaib SA, Mills TD, Sahdev A, et al. (2005) The role of magnetic resonance imaging and ultrasound in patients with adnexal masses. Clin Radiol 60:340–348CrossRefPubMed
31.
Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH (2003) Characterization of adnexal mass lesions on MR imaging. Am J Roentgenol 180:1297–1304CrossRef
32.
33.
34.
35.
36.
Salvador S, Gilks B, Kobel M, et al. (2009) The fallopian tube: primary site of most pelvic high-grade serous carcinomas. Int J Gynecol Cancer 19:58–64CrossRefPubMed
37.
Munksgaard PS, Blaakaer J (2011) The association between endometriosis and gynecological cancers and breast cancer: a review of epidemiological data. Gynecol Oncol 123:157–163CrossRefPubMed
38.
Berns EM, Bowtell DD (2012) The changing view of high-grade serous ovarian cancer. Cancer Res 72:2701–2704CrossRefPubMed
39.
Meinhold-Heerlein I, Fotopoulou C, Harter P, et al. (2016) The new WHO classification of ovarian, fallopian tube, and primary peritoneal cancer and its clinical implications. Arch Gynecol Obstet 293:695–700CrossRefPubMed
40.
Kaijser J, Vandecaveye V, Deroose CM, et al. (2014) Imaging techniques for the pre-surgical diagnosis of adnexal tumours. Best Pract Res Clin Obstet Gynaecol 28:683–695CrossRefPubMed
41.
Shim SH, Kim SN, Jung PS, et al. (2016) Impact of surgical staging on prognosis in patients with borderline ovarian tumours: a meta-analysis. Eur J Cancer 54:84–95CrossRefPubMed
42.
Anthoulakis C, Nikoloudis N (2014) Pelvic MRI as the “gold standard” in the subsequent evaluation of ultrasound-indeterminate adnexal lesions: a systematic review. Gynecol Oncol 132:661–668CrossRefPubMed
43.
Van Calster B, Van Hoorde K, Valentin L, et al. (2014) Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ 349:g5920CrossRefPubMedPubMedCentral
44.
Brun JL, Fritel X, Aubard Y, et al. (2014) Management of presumed benign ovarian tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol 183:52–58CrossRefPubMed
45.
Guerriero S, Alcazar JL, Coccia ME, et al. (2002) Complex pelvic mass as a target of evaluation of vessel distribution by color Doppler sonography for the diagnosis of adnexal malignancies: results of a multicenter European study. J Ultrasound Med 21:1105–1111CrossRefPubMed
46.
Valentin L (1999) Prospective cross-validation of Doppler ultrasound examination and gray-scale ultrasound imaging for discrimination of benign and malignant pelvic masses. Ultrasound Obstet Gynecol 14:273–283CrossRefPubMed
47.
Stein SM, Laifer-Narin S, Johnson MB, et al. (1995) Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. Am J Roentgenol 164:381–386CrossRef
48.
Buy JN, Ghossain MA, Hugol D, et al. (1996) Characterization of adnexal masses: combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. Am J Roentgenol 166:385–393CrossRef
49.
Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC (2009) Accuracy of ultrasonography with color Doppler in ovarian tumor: a systematic quantitative review. Int J Gynecol Cancer 19:1214–1220CrossRefPubMed
50.
Sokalska A, Timmerman D, Testa AC, et al. (2009) Diagnostic accuracy of transvaginal ultrasound examination for assigning a specific diagnosis to adnexal masses. Ultrasound Obstet Gynecol 34:462–470CrossRefPubMed
51.
Levine D, Brown DL, Andreotti RF, et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement. Ultrasound Q 26:121–131CrossRefPubMed
52.
Siegelman ES, Outwater EK (1999) Tissue characterization in the female pelvis by means of MR imaging. Radiology 212:5–18CrossRefPubMed
53.
Adusumilli S, Hussain HK, Caoili EM, et al. (2006) MRI of sonographically indeterminate adnexal masses. Am J Roentgenol 187:732–740CrossRef
54.
Tsili AC, Tsampoulas C, Argyropoulou M, et al. (2008) Comparative evaluation of multidetector CT and MR imaging in the differentiation of adnexal masses. Eur Radiol 18:1049–1057CrossRefPubMed
55.
Takeuchi M, Matsuzaki K, Nishitani H (2010) Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 34:173–176CrossRefPubMed
56.
Thomassin-Naggara I, Balvay D, Aubert E, et al. (2012) Quantitative dynamic contrast-enhanced MR imaging analysis of complex adnexal masses: a preliminary study. Eur Radiol 22:738–745CrossRefPubMed
57.
Thomassin-Naggara I, Bazot M, Darai E, et al. (2008) Epithelial ovarian tumors: value of dynamic contrast-enhanced MR imaging and correlation with tumor angiogenesis. Radiology 248:148–159CrossRefPubMed
58.
Thomassin-Naggara I, Toussaint I, Perrot N, et al. (2011) Characterization of complex adnexal masses: value of adding perfusion- and diffusion-weighted MR imaging to conventional MR imaging. Radiology 258:793–803CrossRefPubMed
59.
Spencer JA, Forstner R, Cunha TM, Kinkel K (2010) ESUR guidelines for MR imaging of the sonographically indeterminate adnexal mass: an algorithmic approach. Eur Radiol 20:25–35CrossRefPubMed
60.
Timmerman D, Valentin L, Bourne TH, et al. (2000) Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 16:500–505CrossRefPubMed
61.
Lalwani N, Prasad SR, Vikram R, et al. (2011) Histologic, molecular, and cytogenetic features of ovarian cancers: implications for diagnosis and treatment. Radiographics 31:625–646CrossRefPubMed
62.
Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP (2014) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology 271:126–132CrossRefPubMed
63.
Bal A, Mohan H, Singh SB, Sehgal A (2007) Malignant transformation in mature cystic teratoma of the ovary: report of five cases and review of the literature. Arch Gynecol Obstet 275:179–182CrossRefPubMed
64.
Khashper A, Addley HC, Abourokbah N, et al. (2012) T2-hypointense adnexal lesions: an imaging algorithm. Radiographics 32:1047–1064CrossRefPubMed
65.
Montoriol PF, Mons A, Da Ines D, et al. (2013) Fibrous tumours of the ovary: aetiologies and MRI features. Clin Radiol 68:1276–1283CrossRefPubMed
Metadata
Title
A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system
Authors
Elizabeth A. Sadowski
Jessica B. Robbins
Andrea G. Rockall
Isabelle Thomassin-Naggara
Publication date
01-03-2018
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2018
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-017-1272-7

Other articles of this Issue 3/2018

Abdominal Radiology 3/2018 Go to the issue

OriginalPaper

Safety and efficacy of transcatheter embolization with Glubran®2 cyanoacrylate glue for acute arterial bleeding: a single-center experience with 104 patients

Pictorial Essay

Tumor thrombosis: a peculiar finding associated with pancreatic neuroendocrine neoplasms. A pictorial essay

OriginalPaper

Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results

Pictorial essay

Documentation, coding, and billing: what abdominal radiologists need to know

OriginalPaper

Does intravoxel incoherent motion reliably stage hepatic fibrosis, steatosis, and inflammation?

OriginalPaper

CT colonography: the ideal colorectal cancer screening test
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits